The forecast for bladder malignant neoplasms mortality among Canadian women standardized per hundred thousand stands at a steady value of 2.9 from 2024 to 2026, decreasing slightly to 2.8 for both 2027 and 2028. Given that the mortality rate was also at 2.9 in 2023, there is no significant year-on-year variation observed from 2023 to 2026, reflecting stability in this period. The slight decline in 2027 and 2028 indicates a minor downward trend. Over a five-year span, the compound annual growth rate (CAGR) suggests minimal change.
Potential future trends to monitor include advances in early detection and treatment technologies which may contribute to a further decline in mortality rates. Additionally, public health initiatives aimed at reducing risk factors could influence these outcomes positively over time.
